PTC Therapeutics
PTCT
#2687
Rank
S$8.03 B
Marketcap
S$100.11
Share price
-0.76%
Change (1 day)
55.38%
Change (1 year)

PTC Therapeutics (PTCT) - Cash on Hand

Cash on Hand as of September 2025 : S$2.18 Billion

According to PTC Therapeutics 's latest financial reports the company has S$2.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

PTC Therapeutics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$1.54 B33.79%
2023-12-31S$1.15 B110.3%
2022-12-31S$0.55 B-47.34%
2021-12-31S$1.04 B-28.39%
2020-12-31S$1.46 B57.74%
2019-12-31S$0.92 B197.7%
2018-12-31S$0.31 B21.55%
2017-12-31S$0.25 B-23.71%
2016-12-31S$0.33 B-30.06%
2015-12-31S$0.47 B15.1%
2014-12-31S$0.41 B130.77%
2013-12-31S$0.18 B5315.2%
2012-12-31S$3.33 M-90.95%
2011-12-31S$36.82 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vertex Pharmaceuticals
VRTX
S$8.14 B 272.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.10 B-49.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.27 B-87.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
S$2.43 B 11.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.61 B-72.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.63 B 477.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland